Is family history of liver cancer a risk factor for hepatocellular carcinoma?

Journal of Hepatology

Volumn 50, Issue 2, 2009, Pages 247-248

  Volk, Michael L ^a   Lok, Anna S F ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN DEFICIENCY; CANCER FAMILY; CANCER RISK; CIGARETTE SMOKING; DISEASE MARKER; DNA SYNTHESIS; EDITORIAL; EPIDEMIC; FAMILY HISTORY; GENE MUTATION; HEMOCHROMATOSIS; HEPATITIS B; HEPATITIS C; LIVER CELL CARCINOMA; MULTIVARIATE ANALYSIS; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; RECALL BIAS;

CARCINOMA, HEPATOCELLULAR; FATTY LIVER; HUMANS; LIVER NEOPLASMS; RISK FACTORS;

EID: 58149299654     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.11.009     Document Type: Editorial

References (17)

1. Bosch F.X., Ribes J., Cleries R., and Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9 (2005) 191-211
2. El-Serag H.B., Davila J.A., Petersen N.J., and McGlynn K.A. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med 139 (2003) 817-823
3. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
4. Mazzanti R., Gramantieri L., and Bolondi L. Hepatocellular carcinoma: epidemiology and clinical aspects. Mol Aspects Med 29 (2008) 130-143
5. Marrero J.A., Fontana R.J., Fu S., Conjeevaram H.S., Su G.L., and Lok A.S. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42 (2005) 218-224
6. El-Serag H.B., Tran T., and Everhart J.E. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 126 (2004) 460-468
7. Yu M.W., Chang H.C., Liaw Y.F., Lin S.M., Lee S.D., Liu C.J., et al. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 92 (2000) 1159-1164
8. Chen C.H., Huang G.T., Lee H.S., Yang P.M., Chen D.S., and Sheu J.C. Clinical impact of screening first-degree relatives of patients with hepatocellular carcinoma. J Clin Gastroenterol 27 (1998) 236-239
9. Donato F., Gelatti U., Chiesa R., Albertini A., Bucella E., Boffetta P., et al. A case-control study on family history of liver cancer as a risk factor for hepatocellular carcinoma in North Italy. Brescia HCC Study. Cancer Causes Control 10 (1999) 417-421
10. Hassan M.M., Spitz M.R., Thomas M.B., Curley S.A., Patt Y.Z., Vauthey J.-N., et al. The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States. J Hepatol 50 (2009) 334-341
11. Friedenreich C.M., Howe G.R., and Miller A.B. Recall bias in the association of micronutrient intake and breast cancer. J Clin Epidemiol 46 (1993) 1009-1017
12. Zhu Z.Z., Cong W.M., Liu S.F., Xian Z.H., Wu W.Q., Wu M.C., et al. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection. Cancer Lett 229 (2005) 77-83
13. Yuan J.M., Lu S.C., Van Den Berg D., Govindarajan S., Zhang Z.Q., Mato J.M., et al. Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma. Hepatology 46 (2007) 749-758
14. Marrero J.A., Fontana R.J., Su G.L., Conjeevaram H.S., Emick D.M., and Lok A.S. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 36 (2002) 1349-1354
15. Sanyal A.J. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123 (2002) 1705-1725
16. Evans A.A., Chen G., Ross E.A., Shen F.M., Lin W.Y., and London W.T. Eight-year follow-up of the 90,000-person Haimen City cohort: I. Hepatocellular carcinoma mortality, risk factors, and gender differences. Cancer Epidemiol Biomarkers Prev 11 (2002) 369-376
17. Yu M.W., Yang Y.C., Yang S.Y., Chang H.C., Liaw Y.F., Lin S.M., et al. Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women. Hepatology 36 (2002) 156-163